P
PGEN
Precigen Inc
4.38
-0.13-2.88%After Hours: 4.390 +0.010 +0.23%18:48 02/20 EST
OPEN/PREV CLOSE4.450/4.510
TODAY RANGE4.310-4.601
VOL6.03M
MARKET CAP1.55B
52 WEEK RANGE1.110-5.47
AVG VOL (3M)4.30M
% TURNOVER1.70%
TURNOVER--
P/E (TTM)-3.1270
% RANGE6.41%
EPS(TTM)-1.4007
P/E(FORWARD)-5.5443
P/B37.02
BVPS0.1183
DIVIDEND--
P/S119.67
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.34B
SHARES OUTSTANDING353.82M
NEXT EARNINGS03/17-03/23
FREE FLOAT305.62M
LOT SIZE1
EX-DATE01/19/2017
News
Press Releases
Financial Reports
Profile
Simply Wall St·02/13 17:42
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Standard Of Care Endorsement
Seeking Alpha·02/11 14:34
Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech
Simply Wall St·01/30 23:38
Precigen (PGEN) Is Down 5.7% After Consensus Backs PAPZIMEOS As New First-Line RRP Therapy
Simply Wall St·01/24 15:35
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Becomes Preferred First Line RRP Treatment
Simply Wall St·01/21 16:19
Why Precigen (PGEN) Is Up 5.3% After PAPZIMEOS Becomes First-Line RRP Standard of Care – And What's Next
Simply Wall St·01/15 06:30
Assessing Precigen (PGEN) Valuation After PAPZIMEOS Commercial Momentum And EMA Milestone
Simply Wall St·01/14 03:31
Is PGEN’s PAPZIMEOS Exclusivity Quietly Redefining Its Competitive Moat in Rare Disease Therapy?
Simply Wall St·01/08 12:29
Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic?
Benzinga·12/29/2025 17:33
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Same Industry
Name/Symbol
Change%
Price